Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

Validating the Xerostomia Inventory in a radiation-induced xerostomia population in German language.

Hohenberger R, Baumann I, Plinkert PK, Brinster R, Krisam J, Affolter A, Hein M, Flechsig P, Rathke H, Oladokun D, Lippert BM, Bulut OC.

Oral Dis. 2019 Jul 11. doi: 10.1111/odi.13154. [Epub ahead of print]

PMID:
31295368
2.

Differential Activation of ERK Signaling in HPV-Related Oropharyngeal Squamous Cell Carcinoma.

Rong C, Muller M, Flechtenmacher C, Holzinger D, Dyckhoff G, Bulut OC, Horn D, Plinkert P, Hess J, Affolter A.

Cancers (Basel). 2019 Apr 25;11(4). pii: E584. doi: 10.3390/cancers11040584.

3.

Low SOX2 expression marks a distinct subset of adenoid cystic carcinoma of the head and neck and is associated with an advanced tumor stage.

Thierauf J, Weissinger SE, Veit JA, Affolter A, Laureano NK, Beutner D, Heiduschka G, Kadletz L, Meyer M, Quaas A, Plinkert P, Hoffmann TK, Hess J.

PLoS One. 2018 Mar 29;13(3):e0194989. doi: 10.1371/journal.pone.0194989. eCollection 2018.

4.

The thermal impact of subsurface building structures on urban groundwater resources - A paradigmatic example.

Epting J, Scheidler S, Affolter A, Borer P, Mueller MH, Egli L, García-Gil A, Huggenberger P.

Sci Total Environ. 2017 Oct 15;596-597:87-96. doi: 10.1016/j.scitotenv.2017.03.296. Epub 2017 Apr 17.

PMID:
28426989
5.

Multikinase inhibitors sorafenib and sunitinib as radiosensitizers in head and neck cancer cell lines.

Affolter A, Samosny G, Heimes AS, Schneider J, Weichert W, Stenzinger A, Sommer K, Jensen A, Mayer A, Brenner W, Mann WJ, Brieger J.

Head Neck. 2017 Apr;39(4):623-632. doi: 10.1002/hed.24557. Epub 2017 Feb 21.

PMID:
28221700
6.

Expression of Kallikrein-Related Peptidase 6 in Primary Mucosal Malignant Melanoma of the Head and Neck.

Thierauf J, Veit JA, Lennerz JK, Weissinger SE, Affolter A, Döscher J, Bergmann C, Knopf A, Grünow J, Grünmüller L, Mauch C, Plinkert PK, Hoffmann TK, Hess J.

Head Neck Pathol. 2017 Sep;11(3):314-320. doi: 10.1007/s12105-016-0769-7. Epub 2016 Nov 14.

7.

Targeting irradiation-induced mitogen-activated protein kinase activation in vitro and in an ex vivo model for human head and neck cancer.

Affolter A, Muller MF, Sommer K, Stenzinger A, Zaoui K, Lorenz K, Wolf T, Sharma S, Wolf J, Perner S, Weber KJ, Freier K, Plinkert PK, Hess J, Weichert W.

Head Neck. 2016 Apr;38 Suppl 1:E2049-61. doi: 10.1002/hed.24376. Epub 2016 Feb 26.

PMID:
26918677
8.

Identification and clinical relevance of PD-L1 expression in primary mucosal malignant melanoma of the head and neck.

Thierauf J, Veit JA, Affolter A, Bergmann C, Grünow J, Laban S, Lennerz JK, Grünmüller L, Mauch C, Plinkert PK, Hess J, Hoffmann TK.

Melanoma Res. 2015 Dec;25(6):503-9. doi: 10.1097/CMR.0000000000000197.

PMID:
26352784
9.

Reactive oxygen species activation of MAPK pathway results in VEGF upregulation as an undesired irradiation response.

Drigotas M, Affolter A, Mann WJ, Brieger J.

J Oral Pathol Med. 2013 Sep;42(8):612-9. doi: 10.1111/jop.12056. Epub 2013 Mar 11.

PMID:
23480207
10.

Cancer-associated fibroblasts do not respond to combined irradiation and kinase inhibitor treatment.

Affolter A, Schmidtmann I, Mann WJ, Brieger J.

Oncol Rep. 2013 Feb;29(2):785-90. doi: 10.3892/or.2012.2180. Epub 2012 Dec 10.

PMID:
23232940
11.

Increased radioresistance via G12S K-Ras by compensatory upregulation of MAPK and PI3K pathways in epithelial cancer.

Affolter A, Drigotas M, Fruth K, Schmidtmann I, Brochhausen C, Mann WJ, Brieger J.

Head Neck. 2013 Feb;35(2):220-8. doi: 10.1002/hed.22954. Epub 2012 Feb 2.

PMID:
22302684
12.

Increased basic fibroblast growth factor release and proliferation in xenotransplanted squamous cell carcinoma after combined irradiation/anti-vascular endothelial growth factor treatment.

Fruth K, Weber S, Okcu Y, Noppens R, Klein KU, Joest E, Hedrich J, Thilemann S, Pogorzelski B, Koutsimpelas D, Fischer S, Muennemann K, Affolter A, Heinrich UR, Brochhausen C, Schmidtmann I, Mann WJ, Schmidberger H, Schreiber LM, Brieger J.

Oncol Rep. 2012 May;27(5):1573-9. doi: 10.3892/or.2012.1654. Epub 2012 Jan 26.

PMID:
22294154
13.

Activation of mitogen-activated protein kinase extracellular signal-related kinase in head and neck squamous cell carcinomas after irradiation as part of a rescue mechanism.

Affolter A, Fruth K, Brochhausen C, Schmidtmann I, Mann WJ, Brieger J.

Head Neck. 2011 Oct;33(10):1448-57. doi: 10.1002/hed.21623. Epub 2010 Nov 10.

PMID:
21928417
14.

Gatekeeper mutations mediate resistance to BRAF-targeted therapies.

Whittaker S, Kirk R, Hayward R, Zambon A, Viros A, Cantarino N, Affolter A, Nourry A, Niculescu-Duvaz D, Springer C, Marais R.

Sci Transl Med. 2010 Jun 9;2(35):35ra41. doi: 10.1126/scitranslmed.3000758.

15.

BRAF and NRAS mutations in melanoma: potential relationships to clinical response to HSP90 inhibitors.

Banerji U, Affolter A, Judson I, Marais R, Workman P.

Mol Cancer Ther. 2008 Apr;7(4):737-9. doi: 10.1158/1535-7163.MCT-08-0145. Epub 2008 Mar 28.

16.

Childhood papillary thyroid cancer as second malignancy after successful treatment of rhabdomyosarcoma.

Venkitaraman R, Affolter A, Ahmed M, Thomas V, Pritchard-Jones K, Sharma AK, Marais R, Nutting CM.

Acta Oncol. 2008;47(3):469-72. doi: 10.1080/02841860701864676. No abstract available.

PMID:
18348005
17.

Dual FISH analysis of benign and malignant tumors of the salivary glands and paranasal sinuses.

Götte K, Ganssmann S, Affolter A, Schäfer C, Riedel F, Arens N, Finger S, Hörmann K.

Oncol Rep. 2005 Nov;14(5):1103-7.

PMID:
16211271
18.

Altered expression of cell cycle regulators p21, p27, and p53 in tumors of salivary glands and paranasal sinuses.

Affolter A, Helmbrecht S, Finger S, Hörmann K, Götte K.

Oncol Rep. 2005 Jun;13(6):1089-94.

PMID:
15870926

Supplemental Content

Loading ...
Support Center